SI-BONE, Inc. (SIBN)
USD 13.54
(-2.17%)
USD 13.54
(-2.17%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 61.05 Million USD | 3.04% |
| 2022 | 59.25 Million USD | 5.64% |
| 2021 | 56.08 Million USD | 4.29% |
| 2020 | 53.77 Million USD | -0.41% |
| 2019 | 54 Million USD | 11.74% |
| 2018 | 48.32 Million USD | -70.75% |
| 2017 | 165.21 Million USD | 11.5% |
| 2016 | 148.16 Million USD | 351.43% |
| 2015 | 32.82 Million USD | 48.56% |
| 2014 | 22.09 Million USD | 12.34% |
| 2013 | 19.66 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 58.17 Million USD | -4.71% |
| 2024 Q2 | 59.11 Million USD | 1.61% |
| 2023 Q1 | 55.11 Million USD | -6.98% |
| 2023 Q4 | 61.05 Million USD | 6.59% |
| 2023 Q3 | 57.27 Million USD | 1.52% |
| 2023 FY | 61.05 Million USD | 3.04% |
| 2023 Q2 | 56.41 Million USD | 2.36% |
| 2022 Q4 | 59.25 Million USD | 6.88% |
| 2022 Q3 | 55.43 Million USD | -11.01% |
| 2022 Q2 | 62.29 Million USD | 14.49% |
| 2022 FY | 59.25 Million USD | 5.64% |
| 2022 Q1 | 54.41 Million USD | -2.99% |
| 2021 Q4 | 56.08 Million USD | 11.4% |
| 2021 Q3 | 50.34 Million USD | -5.24% |
| 2021 Q2 | 53.13 Million USD | -1.77% |
| 2021 Q1 | 54.09 Million USD | 0.59% |
| 2021 FY | 56.08 Million USD | 4.29% |
| 2020 FY | 53.77 Million USD | -0.41% |
| 2020 Q3 | 52.28 Million USD | 1.76% |
| 2020 Q2 | 51.38 Million USD | -0.33% |
| 2020 Q1 | 51.54 Million USD | -4.54% |
| 2020 Q4 | 53.77 Million USD | 2.86% |
| 2019 Q4 | 54 Million USD | 3.14% |
| 2019 FY | 54 Million USD | 11.74% |
| 2019 Q2 | 49.37 Million USD | 0.15% |
| 2019 Q3 | 52.35 Million USD | 6.04% |
| 2019 Q1 | 49.29 Million USD | 2.01% |
| 2018 Q2 | 46.42 Million USD | 0.0% |
| 2018 Q3 | 167.82 Million USD | 261.52% |
| 2018 Q4 | 48.32 Million USD | -71.2% |
| 2018 FY | 48.32 Million USD | -70.75% |
| 2018 Q1 | - USD | -100.0% |
| 2017 Q4 | 165.21 Million USD | 0.0% |
| 2017 Q1 | 36.15 Million USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 FY | 165.21 Million USD | 11.5% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | 148.16 Million USD | 351.43% |
| 2015 Q1 | 21.82 Million USD | -1.24% |
| 2015 FY | 32.82 Million USD | 48.56% |
| 2014 Q4 | 22.09 Million USD | 0.0% |
| 2014 FY | 22.09 Million USD | 12.34% |
| 2013 FY | 19.66 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | -11.326% |
| Axonics, Inc. | 82.35 Million USD | 25.873% |
| INVO Bioscience, Inc. | 19.99 Million USD | -205.327% |
| CVRx, Inc. | 39.28 Million USD | -55.415% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 72.629% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1818.639% |
| MaxCyte, Inc. | 36.1 Million USD | -69.081% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -184.112% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 50.752% |
| Sintx Technologies, Inc. | 6.59 Million USD | -825.982% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -19.113% |
| Apyx Medical Corporation | 52.31 Million USD | -16.69% |
| Cutera, Inc. | 518.12 Million USD | 88.217% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -1042.83% |
| NeuroPace, Inc. | 86.99 Million USD | 29.825% |
| IRIDEX Corporation | 24.91 Million USD | -145.043% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 30.464% |
| enVVeno Medical Corporation | 2.43 Million USD | -2407.187% |
| TELA Bio, Inc. | 59.16 Million USD | -3.183% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 90.446% |
| UFP Technologies, Inc. | 118.04 Million USD | 48.282% |
| Modular Medical, Inc. | 2.27 Million USD | -2587.06% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -108.163% |
| LENSAR, Inc. | 22.4 Million USD | -172.435% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 97.218% |
| Surmodics, Inc. | 65.82 Million USD | 7.251% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -491.627% |
| Inogen, Inc. | 121.38 Million USD | 49.704% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -3546.953% |
| RxSight, Inc. | 22.18 Million USD | -175.149% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -14255.215% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -106.382% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -163.897% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -14255.215% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -2413.07% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 41.638% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 91.322% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -139.76% |
| Dynatronics Corporation | 11.78 Million USD | -418.246% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -18.17% |
| InMode Ltd. | 75.91 Million USD | 19.58% |
| Bruker Corporation | 2.83 Billion USD | 97.848% |
| Movano Inc. | 5.97 Million USD | -922.271% |
| Orthofix Medical Inc. | 326.58 Million USD | 81.307% |
| FONAR Corporation | 57.45 Million USD | -6.252% |
| BioSig Technologies, Inc. | 4.68 Million USD | -1203.095% |
| Envoy Medical, Inc. | 9.4 Million USD | -549.33% |
| Align Technology, Inc. | 2.45 Billion USD | 97.512% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -4.597% |
| Talis Biomedical Corporation | 29.22 Million USD | -108.904% |
| Cerus Corporation | 144.3 Million USD | 57.693% |
| 908 Devices Inc. | 37.49 Million USD | -62.843% |
| Nemaura Medical Inc. | 26.37 Million USD | -131.448% |
| Outset Medical, Inc. | 190.91 Million USD | 68.022% |
| NanoVibronix, Inc. | 2.68 Million USD | -2172.897% |
| Venus Concept Inc. | 107.1 Million USD | 42.999% |
| Telesis Bio, Inc. | 40.87 Million USD | -49.365% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 46.433% |
| Quipt Home Medical Corp. | 136.29 Million USD | 55.207% |
| IRadimed Corporation | 20.73 Million USD | -194.416% |
| Tenon Medical, Inc. | 5.56 Million USD | -996.641% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1609.127% |
| Pulmonx Corporation | 60.63 Million USD | -0.683% |
| iCAD, Inc. | 8 Million USD | -663.03% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -381.069% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -3203.732% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -49.668% |
| Semler Scientific, Inc. | 6.27 Million USD | -873.684% |
| Biotricity, Inc. | 35.91 Million USD | -69.964% |
| Cytosorbents Corporation | 29.98 Million USD | -103.599% |
| DexCom, Inc. | 4.19 Billion USD | 98.545% |
| ZimVie Inc. | 795.85 Million USD | 92.329% |
| Aethlon Medical, Inc. | 2.47 Million USD | -2362.041% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -410.534% |
| IceCure Medical Ltd | 4.24 Million USD | -1337.485% |
| PAVmed Inc | 57.13 Million USD | -6.848% |
| Sight Sciences, Inc. | 46.43 Million USD | -31.471% |
| Insulet Corporation | 1.85 Billion USD | 96.71% |
| Profound Medical Corp. | 12.66 Million USD | -382.004% |
| electroCore, Inc. | 8.94 Million USD | -582.504% |
| Bioventus Inc. | 589.79 Million USD | 89.649% |
| InspireMD, Inc. | 8.14 Million USD | -649.816% |
| PAVmed Inc. | 57.13 Million USD | -6.848% |
| Nuwellis, Inc. | 6.78 Million USD | -800.442% |
| OrthoPediatrics Corp. | 72.56 Million USD | 15.864% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -410.534% |
| BrainsWay Ltd. | 15.31 Million USD | -298.655% |
| BIOLASE, Inc. | 35.34 Million USD | -72.711% |
| Beyond Air, Inc. | 29.77 Million USD | -105.038% |
| AxoGen, Inc. | 101.16 Million USD | 39.651% |
| Inari Medical, Inc. | 209.32 Million USD | 70.835% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -2693.012% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -3331.703% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.064% |
| Quanterix Corporation | 78.08 Million USD | 21.815% |
| Viveve Medical, Inc. | 10.84 Million USD | -462.828% |
| LivaNova PLC | 1.15 Billion USD | 94.7% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -246.204% |
| Varex Imaging Corporation | 668.6 Million USD | 90.869% |
| Vivani Medical, Inc. | 25.03 Million USD | -143.849% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -1402.215% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1609.127% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -1149.744% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 94.156% |
| TransMedics Group, Inc. | 568.84 Million USD | 89.268% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -265.963% |
| NeuroMetrix, Inc. | 1.33 Million USD | -4479.469% |
| Spectral AI, Inc. | 12.4 Million USD | -392.299% |
| Hyperfine, Inc. | 9.8 Million USD | -522.959% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 75.604% |
| Biomerica, Inc. | 2.66 Million USD | -2192.527% |
| Bone Biologics Corporation | 831.4 Thousand USD | -7243.018% |
| AVITA Medical, Inc. | 19.86 Million USD | -207.318% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -2993.202% |
| Silk Road Medical, Inc | 114.15 Million USD | 46.521% |